| Structure | Chemical Name | CAS | MF |
|
Ethyl (R)-(+)-1-Boc-4-oxopiperidine-2-carboxylate, 95%
|
357154-16-6
|
C13H21NO5
|
|
(S)-ethyl 4-oxo-1-((R)-1-phenylethyl)piperidine-2-carboxylate
|
357154-19-9
|
C16H21NO3
|
|
Ertapenem Impurity 10
|
357154-27-9
|
C22H27N3O8S
|
|
Cyclopentanone, 2-(hydroxymethyl)-2-(2-propynyl)- (9CI)
|
357157-88-1
|
C9H12O2
|
|
1H-Tetrazole,1-(2-fluorophenyl)-(9CI)
|
357158-11-3
|
C7H5FN4
|
|
ethyl 4-(1H-tetrazol-1-yl)benzoate
|
357159-60-5
|
C10H10N4O2
|
|
1-(2-Iodophenyl)tetrazole
|
357161-75-2
|
C7H5IN4
|
|
(S)-1-(Benzylamino)-2-propanol
|
357165-43-6
|
C10H15NO
|
|
Pemetrexed Disodium Heptahydrate
|
357166-29-1
|
C20H24N5NaO7
|
|
Pemetrexed disodium hemipentahydrate
|
357166-30-4
|
C20H24N5NaO7
|
|
ETHANONE, 1-[5-CHLORO-3-NITRO-2-[(4-NITROBENZOYL)OXY]PHENYL]-
|
357166-49-5
|
C15H9ClN2O7
|
|
BENZOIC ACID, 4-CHLORO-, 2-ACETYL-4-CHLORO-6-NITROPHENYL ESTER
|
357166-50-8
|
C15H9Cl2NO5
|
|
ETHANONE, 1-[2-[(4-AMINOBENZOYL)OXY]-5-CHLORO-3-NITROPHENYL]-
|
357166-51-9
|
C15H11ClN2O5
|
|
1,3-PROPANEDIONE, 1-(5-CHLORO-2-HYDROXY-3-NITROPHENYL)-3-(4-NITROPHENYL)-
|
357166-56-4
|
C15H9ClN2O7
|
|
1,3-PROPANEDIONE, 1-(5-CHLORO-2-HYDROXY-3-NITROPHENYL)-3-(4-CHLOROPHENYL)-
|
357166-57-5
|
C15H9Cl2NO5
|
|
1,3-PROPANEDIONE, 1-(4-AMINOPHENYL)-3-(5-CHLORO-2-HYDROXY-3-NITROPHENYL)-
|
357166-58-6
|
C15H11ClN2O5
|
|
3,5-Difluoro-4-iodobenzaldehyde
|
357166-64-4
|
C7H3F2IO
|
|
Cyclohexaneacetonitrile, alpha,2-dihydroxy- (9CI)
|
357166-84-8
|
C8H13NO2
|
|
Thiotriazolin
|
357172-63-5
|
C9H16N4O3S
|
|
7-Oxabicyclo[4.1.0]heptane, 3-(1-methylethenyl)-
|
357175-33-8
|
C9H14O
|
|
2-Propanone, 1-(4,5-dihydroxy-2-nitrophenyl)- (9CI)
|
357179-16-9
|
C9H9NO5
|
|
3-Amino-3-methyl-1-butanol Hydrochloride
|
357185-97-8
|
C5H14ClNO
|
|
tert-butyl 5-methoxy-1H-pyrrolo[2,3-c]pyridine-1-carboxylate
|
357187-17-8
|
C13H16N2O3
|
|
2H-1-Benzopyran-2-one,3,4-dihydro-6,7-dihydroxy-4,4-dimethyl-(9CI)
|
357187-41-8
|
C11H12O4
|
|
Posaconazole Impurity 51
|
357189-94-7
|
C37H40F2N8O5
|
|
Posaconazole Impurity 43
|
357189-95-8
|
C37H40F2N8O6
|
|
Posaconazole Impurity 42
|
357189-96-9
|
C36H40F2N8O5
|
|
Posaconazole Impurity 44
|
357189-97-0
|
C21H20F2N4O3
|
|
Posaconazole Impurity 13
|
357189-98-1
|
C37H40F2N8O6
|
|
β-Gal-NONOate
|
357192-77-9
|
C10H19N3O7
|
|
BETA-GAL-NONOATE
|
357192-78-0
|
C10H19N3O7
|
|
2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3,5,7-trihydroxy-4H-chroMen-4-one
|
357194-03-7
|
C28H18O7
|
|
MS-PEG3-THP
|
357204-84-3
|
C12H24O7S
|
|
Cyclopentane, 1-ethenyl-2-(2-methoxyethylidene)- (9CI)
|
357204-95-6
|
C10H16O
|
|
Carbamic acid, [(1R)-2-hydroxy-1-(mercaptomethyl)ethyl]-, 1,1-dimethylethyl
|
357205-17-5
|
C8H17NO3S
|
|
2,6-BIS((3AR,8AS)-8H-INDENO(1,2-D)OXAZO&
|
357209-32-6
|
C25H19N3O2
|
|
Benzeneacetic acid, 4-methoxy-, [[5-(dimethylamino)-2-furanyl]methylene]hydrazide (9CI)
|
357217-47-1
|
C16H19N3O3
|
|
Benzoic acid, 2-amino-, [[5-(dimethylamino)-2-furanyl]methylene]hydrazide (9CI)
|
357217-81-3
|
C14H16N4O2
|
|
Benzeneacetic acid, 4-chloro-, [[5-(dimethylamino)-2-furanyl]methylene]hydrazide (9CI)
|
357218-47-4
|
C15H16ClN3O2
|
|
9,9-Bis(2-ethylhexyl)-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorene
|
357219-41-1
|
C41H64B2O4
|
|
4-BENZOYL-2-METHYL-1-[(7-OXIDO-1H-PYRROLO[2,3-B] PYRIDIN-3-YL)OXOACETYL]-PIPERAZINE
|
357262-90-9
|
C21H20N4O4
|
|
SINOVA SL-02580
|
357263-13-9
|
C22H22N4O4
|
|
(R)-2-METHYL-4-BENZOYLPIPERAZINE
|
357263-39-9
|
C12H16N2O
|
|
1H-Pyrrolo[2,3-c]pyridine,4-methoxy-(9CI)
|
357263-40-2
|
C8H8N2O
|
|
7-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE
|
357263-41-3
|
C7H5ClN2
|
|
1H-Pyrrolo[3,2-b]pyridine,7-methyl-(9CI)
|
357263-42-4
|
C8H8N2
|
|
5-chloro-7-methyl-1H-pyrrolo[3,2-b]pyridine
|
357263-43-5
|
C8H7ClN2
|
|
7-(benzyloxy)-1H-pyrrolo[3,2-b]pyridine
|
357263-44-6
|
C14H12N2O
|
|
2-Bromo-4-chloropyridin-3-amine
|
357263-45-7
|
C5H4BrClN2
|
|
7-Chloro-1H-pyrrolo[3,2-b]pyridine
|
357263-48-0
|
C7H5ClN2
|
|
METHYL 7-AZAINDOLE-3-GLYOXYLATE
|
357263-49-1
|
C10H8N2O3
|
|
methyl 2-oxo-2-(1H-pyrrolo[3,2-c]pyridin-3-yl)acetate
|
357263-50-4
|
C10H8N2O3
|
|
ALFA-OXO-1H-PYRROLO-[2,3B]PYRIDINE-3-ACETIC ACID MONOPOTASSIUM SALT
|
357263-59-3
|
C9H7KN2O3
|
|
1H-Pyrrolo[2,3-c]pyridine, 7-chloro-4-fluoro-
|
357263-69-5
|
C7H4ClFN2
|
|
2-[2-(3-methoxybenzylidene)hydrazino]-N-(4-methoxyphenyl)-2-oxoacetamide
|
357267-63-1
|
C17H17N3O4
|
|
ethanediamide, N-(2-hydroxyethyl)-N'-(4-methylphenyl)-
|
357268-38-3
|
C11H14N2O3
|
|
Fmoc-β-HomoTrp(Boc)-OH
|
357271-55-7
|
C32H32N2O6
|
|
Pyrazolo[1,5-a]pyrimidine-3,5-diamine, 6-methyl-
|
357272-72-1
|
C7H9N5
|
|
ALPHA-(TRIFLUOROMETHYL)ETHENYL BORONIC ACID
|
357274-85-2
|
C3H4BF3O2
|
|
Lopinavir Metabolite M-3/M-4
|
357275-54-8
|
C37H48N4O6
|
|
Mal-PEG12-acid
|
357277-61-3
|
|
|
4-ArM PEGn-MAL 2K, 5K, 10K, 20K
|
357277-62-4
|
(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC29H32N4O12
|
|
3,4-Pyrrolidinediol, 2-ethenyl-1-(phenylmethyl)-, (2R,3S,4S)- (9CI)
|
357278-44-5
|
C13H17NO2
|
|
Acetonitrile, (cycloheptylidenehydrazino)oxo- (9CI)
|
357281-59-5
|
C9H13N3O
|
|
2-Furanpropanoic acid, alpha-fluoro-beta-oxo-, ethyl ester (9CI)
|
357286-30-7
|
C9H9FO4
|
|
(4-Methylpyridin-2-yl)methanamine dihydrochloride
|
357287-88-8
|
C7H11ClN2
|
|
(5-Methylpyridin-2-yl)methanamine dihydrochloride
|
357287-98-0
|
C7H12Cl2N2
|
|
(3-Methylpyridin-2-yl)methanamine hydrochloride
|
357288-02-9
|
C7H11ClN2
|
|
2-Furancarboxylicacid,4-cyano-,methylester(9CI)
|
357289-65-7
|
C7H5NO3
|
|
2-Butyn-1-amine,N-methyl-4-phenoxy-(9CI)
|
357290-69-8
|
C11H13NO
|
|
2-Thiophenecarboxamide,N-[3-(dimethylamino)phenyl]-(9CI)
|
357291-91-9
|
C13H14N2OS
|
|
Acetonitrile, oxo[(phenylmethylene)hydrazino]- (9CI)
|
357294-38-3
|
C9H7N3O
|
|
Acetonitrile, [[(4-ethoxyphenyl)methylene]hydrazino]oxo- (9CI)
|
357294-45-2
|
C11H11N3O2
|
|
Acetic acid, [1-(4-ethoxyphenyl)ethylidene]hydrazide (9CI)
|
357294-71-4
|
C12H16N2O2
|
|
Acetic acid, (4-cyano-2,2-dimethylbutylidene)hydrazide (9CI)
|
357295-15-9
|
C9H15N3O
|
|
Acetonitrile, [[1-(2,5-dihydroxyphenyl)ethylidene]hydrazino]oxo- (9CI)
|
357295-86-4
|
C10H9N3O3
|
|
Acetonitrile, [(1-methyl-4-piperidinylidene)hydrazino]oxo- (9CI)
|
357297-08-6
|
C8H12N4O
|
|
1-[3-(1,3-DIHYDRO-2H-ISOINDOL-2-YL)PHENYL]-1-ETHANONE
|
357302-54-6
|
C16H15NO
|
|
2-METHYL-INDOLIZINE-1,3-DICARBALDEHYDE
|
357317-99-8
|
C11H9NO2
|
|
N-(2,3-DIMETHYLPHENYL)-3,5-DIMETHYL-4-ISOXAZOLECARBOXAMIDE
|
357326-67-1
|
C14H16N2O2
|
|
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE
|
357326-79-5
|
C10H15NO3
|
|
1,3-Dioxolane-4-carboxaldehyde, 4-ethyl-2,2-dimethyl- (9CI)
|
357330-15-5
|
C8H14O3
|
|
3-Thiophenecarboxylicacid,2-amino-4-ethyl-,ethylester(9CI)
|
357332-70-8
|
C9H13NO2S
|
|
1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)-
|
357334-83-9
|
C11H20N2O2
|
|
Brivaracetam (Racemate)
|
357335-87-6
|
C11H20N2O2
|
|
(4S)-BrivaracetaM
|
357336-19-7
|
C11H20N2O2
|
|
Brivaracetam
|
357336-20-0
|
C11H20N2O2
|
|
Seletracetam
|
357336-74-4
|
C10H14F2N2O2
|
|
Brivaracetam (alfaR, 4S)-Isomer
|
357336-99-3
|
C11H20N2O2
|
|
Brivaracetam (alfaR, 4R)-Isomer
|
357337-00-9
|
C11H20N2O2
|
|
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide
|
357338-13-7
|
C11H18N2O2
|
|
4-(3-CHLOROPHENYL)PYRROLIDIN-2-ONE
|
357338-16-0
|
C10H10ClNO
|
|
Brivaracetam Impurity 7 HCl
|
357338-46-6
|
C13H27ClN2O3
|
|
ZNAF-2 DA
|
357339-96-9
|
C38H32N4O7
|
|
2-amino-(1,6-dimethylfuro(3,2-e)imidazo(4,5-b))pyridine
|
357383-27-8
|
C10H10N4O
|
|
Carbamic acid, [(1R)-1-(2S)-oxiranylethyl]-, 1,1-dimethylethyl ester (9CI)
|
357385-69-4
|
C9H17NO3
|
|
Carbamic acid, [(1R)-1-(2R)-oxiranylethyl]-, 1,1-dimethylethyl ester (9CI)
|
357385-70-7
|
C9H17NO3
|
|
4-[[(5-chloro-2-methyl-phenyl)-phenylsulfonyl-amino]methyl]benzoic acid
|
357391-80-1
|
C21H18ClNO4S
|
|
1H-Indole-5,6-diol, 2,3-dihydro-1,3,3-trimethyl-2-methylene- (9CI)
|
357397-42-3
|
C12H15NO2
|
|
1H-Indole-4,5-diol, 2,3-dihydro-1,3,3-trimethyl-2-methylene- (9CI)
|
357397-44-5
|
C12H15NO2
|